Researchers from the Children’s Oncology Group (“COG”) have demonstrated that a new experimental immunotherapy treatment using the chimeric monoclonal antibody ch14.18, that targets a specific carbohydrate/lipid molecule ganglioside, GD2 which is present on the surface of neuroblastoma tumor cells and cytokines IL-2 and GM-CSF resulted in a 20% improvement in cure rates compared to the [...]
Entries Tagged as ‘Research’
August 27, 2009
Experimental Immunotherapy Markedly Improves Cure Rate for Children With Neuroblastoma
August 5, 2009
CURE CHILDHOOD CANCER ANNOUNCES $1 MILLION IN RESEARCH GRANTS
Even in tough economic times, CURE Childhood Cancer’s commitment to research stands strong. CURE recently announced $1 million in research grants to researchers at the Aflac Cancer Center and Blood Disorders Service at Children’s Healthcare of Atlanta and Emory University, bringing CURE’s total investment in research over the last 3 years to nearly $3.2 [...]
July 17, 2009
What exactly does CURE Childhood Cancer fund?
CURE Childhood Cancer’s vision is to find a cure for childhood cancer in our lifetime. We at CURE believe this is fully attainable and in efforts to get their we focus on three areas: research into childhood cancer, the most critical and urgent needs of patients and their families and eduction to support the future [...]
May 5, 2009
Pediatric Gene Study Brings Hope to Cancer Patients
The Director of the National Cancer Institute offered the challenge: develop a molecular classification system for tumors. Those who study childhood cancer prepared a proposal at once, since children are the perfect model for such work. That’s because it is usually just a single catastrophic genomic insult which leads to childhood cancer, while adult cases [...]
April 30, 2009
The State of Childhood Cancer
CURE Childhood Cancer is dedicated to discovering a cure for childhood cancer through cutting edge research and providing support to patients and their families through our innovative programming.
Since its inception in 1975, CURE has focused on improving the care, quality of life, and survival rate of children with cancer. The founders – parents and a [...]
January 13, 2009
Gene Abnormality Found To Predict Childhood Leukemia Relapse
Scientists have identified mutations in a gene that predict a high likelihood of relapse in children with acute lymphoblastic leukemia (ALL). Although the researchers caution that further research is needed to determine how changes in the gene, called IKZF1 or IKAROS, lead to leukemia relapse, the findings are likely to provide the basis for future [...]
November 18, 2008
Checking in with CURE Fellows: Reflections And Goals
Two years ago, we introduced you to Dr. Tanya Watt and Dr. Wes Miller, two young doctors and extraordinary humanitarians who were entering the fellowship training program at the Aflac Cancer Center and Blood Disorders Service of Children’s Healthcare of Atlanta. CURE Childhood Cancer fully funded this specialty training then, and has continued to [...]
November 6, 2008
The First Sam Robb Fellow – Dr. Tanya Watt
Friends,
Thanks to your support over the past year with the loss of Sam, we have established a Named Fund with CURE Childhood Cancer. The purpose of the Sam Robb Fund is to support one of two Pediatric Research Fellows at the EMORY/Children’s Healthcare of Atlanta.
Saturday evening, June 21st, we introduced Dr. Tanya Watt as the [...]
November 6, 2008
Childhood Cancer is Cureable in your Lifetime
The term ‘cancer research’ can be amorphous. It certainly has a positive connotation. It suggests commitment and progress toward a worthwhile goal. Being amorphous though, it’s hard to get your arms around it. It’s tough, especially for lay people, to understand the nature and scope of the research. Moreover, it’s tough to hold it accountable.
Donating [...]
